Cargando…
Infantile hemangiomas: a 7-year experience of a single-center
OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kap...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683828/ https://www.ncbi.nlm.nih.gov/pubmed/29151787 http://dx.doi.org/10.15386/cjmed-781 |
_version_ | 1783278367829655552 |
---|---|
author | BOTA, MĂDĂLINA POPA, GHEORGHE BLAG, CRISTINA LUCIA LEUCUTA, DANIEL-CORNELIU TĂTARU, ALEXANDRU |
author_facet | BOTA, MĂDĂLINA POPA, GHEORGHE BLAG, CRISTINA LUCIA LEUCUTA, DANIEL-CORNELIU TĂTARU, ALEXANDRU |
author_sort | BOTA, MĂDĂLINA |
collection | PubMed |
description | OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution. CONCLUSIONS: Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects. |
format | Online Article Text |
id | pubmed-5683828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Iuliu Hatieganu University of Medicine and Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-56838282017-11-17 Infantile hemangiomas: a 7-year experience of a single-center BOTA, MĂDĂLINA POPA, GHEORGHE BLAG, CRISTINA LUCIA LEUCUTA, DANIEL-CORNELIU TĂTARU, ALEXANDRU Clujul Med Original Research OBJECTIVES: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic. METHODS: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic. RESULTS: We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution. CONCLUSIONS: Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects. Iuliu Hatieganu University of Medicine and Pharmacy 2017 2017-10-20 /pmc/articles/PMC5683828/ /pubmed/29151787 http://dx.doi.org/10.15386/cjmed-781 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License |
spellingShingle | Original Research BOTA, MĂDĂLINA POPA, GHEORGHE BLAG, CRISTINA LUCIA LEUCUTA, DANIEL-CORNELIU TĂTARU, ALEXANDRU Infantile hemangiomas: a 7-year experience of a single-center |
title | Infantile hemangiomas: a 7-year experience of a single-center |
title_full | Infantile hemangiomas: a 7-year experience of a single-center |
title_fullStr | Infantile hemangiomas: a 7-year experience of a single-center |
title_full_unstemmed | Infantile hemangiomas: a 7-year experience of a single-center |
title_short | Infantile hemangiomas: a 7-year experience of a single-center |
title_sort | infantile hemangiomas: a 7-year experience of a single-center |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683828/ https://www.ncbi.nlm.nih.gov/pubmed/29151787 http://dx.doi.org/10.15386/cjmed-781 |
work_keys_str_mv | AT botamadalina infantilehemangiomasa7yearexperienceofasinglecenter AT popagheorghe infantilehemangiomasa7yearexperienceofasinglecenter AT blagcristinalucia infantilehemangiomasa7yearexperienceofasinglecenter AT leucutadanielcorneliu infantilehemangiomasa7yearexperienceofasinglecenter AT tatarualexandru infantilehemangiomasa7yearexperienceofasinglecenter |